Saturday, July 2, 2011 7:09 PM
|
CCSVI in Multiple Sclerosis
McDonald said he was "ecstatic" when he heard the government's announcement, saying a randomized, controlled, double-armed trial -- during which doctors follow a group receiving the treatment and a group that does not -- will conclusively determine the treatment's effectiveness, as well as risks. Feds to fund clinical trials of controversial MS therapywww.ctv.ca Health Minister Leona Aglukkaq is giving the go-ahead for clinical trials of a controversial treatment for multiple sclerosis patients.
|